LeonaBio (LONA) Capital Expenditures (2020 - 2024)

LeonaBio (LONA) has 5 years of Capital Expenditures data on file, last reported at $28000.0 in Q2 2024.

• On a quarterly basis, Capital Expenditures fell 15.15% year-over-year to $28000.0 in Q2 2024; TTM through Dec 2024 was $33000.0, a 89.14% decrease from a year earlier, with the FY2024 full-year figure at $33000.0, down 89.14% from the prior year.
• Capital Expenditures for Q2 2024 stood at $28000.0, up from $5000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for LONA reached as high as $2.3 million in Q4 2020 and fell as low as $1000.0 in Q4 2022.
• Historically, Capital Expenditures has averaged $357533.3 across 5 years, with a median of $128000.0 in 2021.
• On a YoY basis, Capital Expenditures climbed as much as 1207.02% in 2022 and fell as far as 99.9% in 2022.
• Year by year, Capital Expenditures stood at $2.3 million in 2020, then slumped by 54.46% to $1.0 million in 2021, then tumbled by 99.9% to $1000.0 in 2022, then surged by 2900.0% to $30000.0 in 2023, then declined by 6.67% to $28000.0 in 2024.
• Per Business Quant data, the three most recent Capital Expenditures figures were $28000.0 in Q2 2024, $5000.0 in Q1 2024, and $30000.0 in Q3 2023.